Alfred Cheung

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi request reprint Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study
    Alfred K Cheung
    VA Salt Lake City Healthcare System and Department of Medicine, University of Utah, Salt Lake City, Utah 84112, USA
    J Am Soc Nephrol 17:546-55. 2006
  2. pmc Modelling ultrasound-induced mild hyperthermia of hyperplasia in vascular grafts
    Mark R Brinton
    Department of Electrical and Computer Engineering, University of Utah, Salt Lake City, USA
    Theor Biol Med Model 8:42. 2011
  3. ncbi request reprint Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
    A K Cheung
    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
    Kidney Int 58:353-62. 2000
  4. pmc Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients
    Alfred K Cheung
    Medical Service, University of Utah, Salt Lake City, UT 84112, USA
    Clin J Am Soc Nephrol 3:69-77. 2008
  5. pmc Pathogenesis and local drug delivery for prevention of vascular access stenosis
    Alfred K Cheung
    Veterans Affair Salt Lake City Healthcare System, Salt Lake City, Utah, USA
    J Ren Nutr 18:140-5. 2008
  6. ncbi request reprint Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study
    Alfred K Cheung
    Veterans Affairs Salt Lake City Healthcare System and University of Utah, Salt Lake City, 84112, USA
    Kidney Int 65:2380-9. 2004
  7. ncbi request reprint Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study
    Alfred K Cheung
    Veterans Affairs Salt Lake City Healthcare System and Department of Medicine, University of Utah, Salt Lake City, Utah 84112, USA
    J Am Soc Nephrol 14:3251-63. 2003
  8. ncbi request reprint Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients
    Alfred K Cheung
    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
    J Am Soc Nephrol 13:2345-52. 2002
  9. doi request reprint Is lipid control necessary in hemodialysis patients?
    Alfred K Cheung
    Medical Service, Veterans Affairs Salt Lake City Healthcare System and Division of Nephrology and Hypertension and Dialysis Program, University of Utah, Salt Lake City, Utah, USA
    Clin J Am Soc Nephrol 4:S95-101. 2009
  10. ncbi request reprint Association of obesity with inflammation in chronic kidney disease: a cross-sectional study
    Nirupama Ramkumar
    Division of Nephrology and Hypertension, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA
    J Ren Nutr 14:201-7. 2004

Research Grants

Collaborators

Detail Information

Publications65

  1. ncbi request reprint Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study
    Alfred K Cheung
    VA Salt Lake City Healthcare System and Department of Medicine, University of Utah, Salt Lake City, Utah 84112, USA
    J Am Soc Nephrol 17:546-55. 2006
    ..05 to 1.19; P = 0.001), after adjustment for residual kidney urea clearance and number of prestudy years on dialysis. This association is supportive of the potential value of beta(2)M as a marker to guide chronic hemodialysis therapy...
  2. pmc Modelling ultrasound-induced mild hyperthermia of hyperplasia in vascular grafts
    Mark R Brinton
    Department of Electrical and Computer Engineering, University of Utah, Salt Lake City, USA
    Theor Biol Med Model 8:42. 2011
    ..The goal was to determine whether ultrasound exposure of an ePTFE graft can generate temperatures sufficient to prevent cell growth on the graft without damaging nearby soft tissues and blood...
  3. ncbi request reprint Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
    A K Cheung
    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
    Kidney Int 58:353-62. 2000
    ..Cardiovascular diseases are the most common causes of death among chronic hemodialysis patients, yet the risk factors for these events have not been well established...
  4. pmc Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients
    Alfred K Cheung
    Medical Service, University of Utah, Salt Lake City, UT 84112, USA
    Clin J Am Soc Nephrol 3:69-77. 2008
    ....
  5. pmc Pathogenesis and local drug delivery for prevention of vascular access stenosis
    Alfred K Cheung
    Veterans Affair Salt Lake City Healthcare System, Salt Lake City, Utah, USA
    J Ren Nutr 18:140-5. 2008
    ..Because of the chronic nature of the stimuli, strategies that allow for the ready replenishment of the drug depot are preferable and are currently under development...
  6. ncbi request reprint Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study
    Alfred K Cheung
    Veterans Affairs Salt Lake City Healthcare System and University of Utah, Salt Lake City, 84112, USA
    Kidney Int 65:2380-9. 2004
    ....
  7. ncbi request reprint Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study
    Alfred K Cheung
    Veterans Affairs Salt Lake City Healthcare System and Department of Medicine, University of Utah, Salt Lake City, Utah 84112, USA
    J Am Soc Nephrol 14:3251-63. 2003
    ..The subgroup results that demonstrate that patients with different durations of dialysis are affected differently by high-flux dialysis are interesting and require further study for confirmation...
  8. ncbi request reprint Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients
    Alfred K Cheung
    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
    J Am Soc Nephrol 13:2345-52. 2002
    ..In addition, awareness of these variations might facilitate the interpretation of laboratory results and the clinical treatment of these patients...
  9. doi request reprint Is lipid control necessary in hemodialysis patients?
    Alfred K Cheung
    Medical Service, Veterans Affairs Salt Lake City Healthcare System and Division of Nephrology and Hypertension and Dialysis Program, University of Utah, Salt Lake City, Utah, USA
    Clin J Am Soc Nephrol 4:S95-101. 2009
    ..More research efforts should be directed toward these dyslipidemic states and the multitude of other putative cardiovascular risk factors in dialysis patients...
  10. ncbi request reprint Association of obesity with inflammation in chronic kidney disease: a cross-sectional study
    Nirupama Ramkumar
    Division of Nephrology and Hypertension, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA
    J Ren Nutr 14:201-7. 2004
    ..We examined the cross-sectional association of body mass index (BMI) with CRP in patients with chronic kidney disease (CKD)...
  11. ncbi request reprint Perivascular tissue pharmacokinetics of dipyridamole
    Kosalaram Goteti
    Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, 421 Wakara Way, 318, Salt Lake City, Utah 84108, USA
    Pharm Res 23:718-28. 2006
    ..The tissue diffusivity (D(g)) and partitioning (K) for dipyridamole were determined and a model was developed to examine the relationship between perivascular dose and local dipyridamole tissue concentrations...
  12. ncbi request reprint Lack of synergistic effects of metabolic syndrome and plasma fibrinogen on coronary events and mortality in moderate CKD
    Nirupama Ramkumar
    Division of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, UT, USA
    Am J Kidney Dis 49:356-64. 2007
    ..Metabolic syndrome and inflammation are interlinked in patients with moderate chronic kidney disease (CKD)...
  13. ncbi request reprint Expression of C-reactive protein in myointimal hyperplasia in a porcine arteriovenous graft model
    Tadashi Kuji
    Department of Medicine, University of Utah and Medical Services, Veterans Affairs Salt Lake City Healthcare System, UT 84112, USA
    Nephrol Dial Transplant 22:2469-75. 2007
    ....
  14. ncbi request reprint The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis
    Alexander S Goldfarb-Rumyantzev
    Division of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, UT, USA
    Am J Kidney Dis 50:791-802. 2007
    ..The effect of lipid-lowering therapy on clinical outcomes in peritoneal dialysis patients has not been carefully addressed...
  15. pmc Neointimal hyperplasia associated with synthetic hemodialysis grafts
    Li Li
    Department of Medicine, University of Utah, Salt Lake City, Utah, USA
    Kidney Int 74:1247-61. 2008
    ..Successful prevention of graft stenosis would provide a superior alternative to the native fistula as hemodialysis vascular access...
  16. ncbi request reprint Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel
    Takahisa Masaki
    Departments of Medicine, Bioengineering, Pathology, Pharmaceutics, and Surgery, and Animal Resource Center, University of Utah, Salt Lake City, Utah, USA
    Kidney Int 66:2061-9. 2004
    ..We examined the feasibility of local drug delivery to inhibit neointimal hyperplasia at dialysis grafts in a canine model...
  17. ncbi request reprint Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model
    Li Li
    Department of Medicine, University of Utah, Salt Lake City, UT 84112, USA
    Nephrol Dial Transplant 22:3139-46. 2007
    ..The nature of the proliferating cells in these lesions is not well understood. A better understanding of the cells contributing to NH is important to the development of preventive strategies...
  18. pmc Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft
    Shawn C Owen
    Department of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, 301 Skaggs Hall, 30 South 2000 East, Salt Lake City, UT 84112, USA
    J Control Release 146:23-30. 2010
    ..In addition, MRI is useful for the monitoring of the location of the drug depot...
  19. ncbi request reprint A population-based assessment of the familial component of chronic kidney disease mortality
    Alexander S Goldfarb-Rumyantzev
    Division of Nephrology and Hypertension and Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA
    Am J Nephrol 26:142-8. 2006
    ..This is the first population-based analysis of the familial component of ESRD and non-ESRD CKD...
  20. ncbi request reprint Cellular pharmacokinetics and pharmacodynamics of dipyridamole in vascular smooth muscle cells
    Weiwei Zhu
    Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84108, USA
    Biochem Pharmacol 72:956-64. 2006
    ....
  21. ncbi request reprint Evaluation of histological techniques for quantifying haemodialysis arteriovenous (AV) graft hyperplasia
    Christi M Terry
    Department of Medicine, University of Utah and Medical Service, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT 84112 5350, USA
    Nephrol Dial Transplant 21:3172-9. 2006
    ..We identified sources of variability in three histological methods for assessing hyperplasia in a porcine AV graft model...
  22. ncbi request reprint Kinetics of urea and beta-microglobulin during and after short hemodialysis treatments
    John K Leypoldt
    VA Salt Lake City Health Care System, Salt Lake City, Utah, USA
    Kidney Int 66:1669-76. 2004
    ....
  23. ncbi request reprint The association of lipid levels with mortality in patients on chronic peritoneal dialysis
    Arsalan N Habib
    Dialysis Program, University of Utah School of Medicine, 30 North Medical Drive, Salt Lake City, UT 84132, USA
    Nephrol Dial Transplant 21:2881-92. 2006
    ..The present study evaluated the association of serum TC and triglycerides with clinical outcomes in chronic peritoneal dialysis (PD) patients...
  24. doi request reprint Familiality of cardiovascular mortality in end-stage renal disease patients
    Natalie Naiman
    Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, Utah, USA
    Am J Nephrol 29:237-43. 2009
    ..24, 95% CI 1.01-1.49). In conclusion, this study suggests that, in addition to many putative risk factors, the increased risk of CV death in ESRD patients may have a familial contribution...
  25. pmc Using the stochastic collocation method for the uncertainty quantification of drug concentration due to depot shape variability
    J Samuel Preston
    Scientific Computing and Imaging Institute and the School of Computing, University of Utah, Salt Lake City, UT 84112, USA
    IEEE Trans Biomed Eng 56:609-20. 2009
    ..We demonstrate that once the underlying stochastic process is characterized, quantification of the introduced variability is quite straightforward and provides an important step in the validation and verification process...
  26. ncbi request reprint Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients
    Srinivasan Beddhu
    Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah 84112, USA
    J Ren Nutr 17:372-80. 2007
    ..Protein-energy wasting and inflammation are common and associated with an increased risk of mortality in hemodialysis (HD) patients. We examined the extent to which they mediate the associations of each other with death in this population...
  27. doi request reprint PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms
    Li Li
    Division of Nephrology and Hypertension, University of Utah, Salt Lake City, UT, USA
    J Cell Biochem 112:289-98. 2011
    ..These results may provide an explanation for the differential susceptibility to proliferative vascular diseases of arteries and veins...
  28. doi request reprint Misoprostol effects on diclofenac-induced cardiorenal changes in salt-sensitive patients with hypertension: the MEDIC Study
    Mark A Munger
    Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah 84112 5820, USA
    Pharmacotherapy 28:834-42. 2008
    ..To determine whether coadministration of misoprostol with the nonsteroidal antiinflammatory drug diclofenac lessens the increase in blood pressure and improves the alterations in renal hemodynamics induced by diclofenac...
  29. pmc Longitudinal assessment of hyperplasia using magnetic resonance imaging without contrast in a porcine arteriovenous graft model
    Christi M Terry
    Department of Medicine, Division of Nephrology and Hypertension, University of Utah, Salt Lake City, UT 84112, USA
    Acad Radiol 16:96-107. 2009
    ..The authors report the use of magnetic resonance (MR) imaging (MRI) without contrast agent to monitor tissue hyperplasia formation as well as luminal area in a porcine model of AV graft stenosis...
  30. pmc Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease
    Srinivasan Beddhu
    Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah, USA
    Clin J Am Soc Nephrol 4:1805-10. 2009
    ....
  31. ncbi request reprint Relationship between volume status and blood pressure during chronic hemodialysis
    John K Leypoldt
    University of Utah, Salt Lake City, Utah 84112 5350, USA
    Kidney Int 61:266-75. 2002
    ..Specifically, the effect of interdialytic fluid accumulation (or intradialytic fluid removal) on BP is controversial...
  32. ncbi request reprint In vitro pharmacological inhibition of human vascular smooth muscle cell proliferation for the prevention of hemodialysis vascular access stenosis
    Takahisa Masaki
    Division of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, Utah, USA
    Blood Purif 22:307-12. 2004
    ..Quiescent cells were cultured in the presence of growth factors, fetal bovine serum and incremental concentrations of the test drug. Cell proliferation was assessed by the MTT reduction assay...
  33. ncbi request reprint Duration of end-stage renal disease and kidney transplant outcome
    Alex Goldfarb-Rumyantzev
    University of Utah Health School of Medicine, Salt Lake City, UT, USA
    Nephrol Dial Transplant 20:167-75. 2005
    ..The goal of the study was to characterize the relationship between the duration of dialysis vs allograft and patient survival...
  34. ncbi request reprint Impact of timing of initiation of dialysis on mortality
    Srinivasan Beddhu
    Renal Section, Salt Lake VA Healthcare System, Division of Nephrology and Hypertension, and Division of Clinical Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA
    J Am Soc Nephrol 14:2305-12. 2003
    ..Furthermore, these data do not support earlier initiation of dialysis. Therefore, for patients without clinical indications for initiation of dialysis, the appropriate GFR level for initiation of dialysis is unknown...
  35. ncbi request reprint Creatinine production, nutrition, and glomerular filtration rate estimation
    Srinivasan Beddhu
    Renal Section, Salt Lake VA Healthcare System, Salt Lake City, Utah, USA
    J Am Soc Nephrol 14:1000-5. 2003
    ..The fundamental assumption of the MDRD formula is invalid in patients with advanced renal failure, and the use of this formula in these patients might introduce biases...
  36. ncbi request reprint The association between BP and mortality in patients on chronic peritoneal dialysis
    Alexander S Goldfarb-Rumyantzev
    Division of Nephrology and Hypertension, University of Utah School of Medicine, 85 North Medical Drive, East Rm 201, Salt Lake City, UT 84112 5350, USA
    Nephrol Dial Transplant 20:1693-701. 2005
    ..It is not clear if this is the consequence of uraemia or related to the dialysis type. The goal of this project was to identify the relationship between BP and mortality in patients on chronic peritoneal dialysis (PD)...
  37. ncbi request reprint The role of pre-emptive re-transplant in graft and recipient outcome
    Alexander S Goldfarb-Rumyantzev
    Division of Nephrology, University of Utah Health School of Medicine, Salt Lake City, UT 84112, USA
    Nephrol Dial Transplant 21:1355-64. 2006
    ..The effect of the pre-emptive re-transplant, and of inter-transplant waiting time generally, on graft and recipient survival is not well established...
  38. ncbi request reprint Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysis
    Alexander S Goldfarb-Rumyantzev
    Division of Nephrology and Hypertension, University of Utah, School of Medicine, and VA Salt Lake City Health Care System, Salt Lake City, UT 84112, USA
    Am J Kidney Dis 40:1211-8. 2002
    ..More intensive hemodialysis (HD) regimens (short daily and long thrice-weekly HD) provide potential opportunities for improved patient outcome. An adequate dialysis dose for these regimens cannot be established from the existing literature...
  39. ncbi request reprint Impact of renal failure on the risk of myocardial infarction and death
    Srinivasan Beddhu
    Renal Section, Salt Lake VA Healthcare System, Salt Lake City, Utah, USA
    Kidney Int 62:1776-83. 2002
    ..We examined whether renal failure independently increases the risk of myocardial infarction and death...
  40. ncbi request reprint Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III)
    Srinivasan Beddhu
    Medical Service, Salt Lake Veterans Affairs Healthcare System, Salt Lake City, UT, USA
    Am J Kidney Dis 46:577-86. 2005
    ..Although metabolic syndrome is associated with inflammation in the general population, it is unknown whether similar associations exist in patients with chronic kidney disease...
  41. ncbi request reprint The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival
    Alexander S Goldfarb-Rumyantzev
    University of Utah School of Medicine, Salt Lake City, UT, USA
    Am J Kidney Dis 46:537-49. 2005
    ..The effect of pretransplantation renal replacement therapy (RRT) modality on allograft and recipient survival outcome is not well understood...
  42. ncbi request reprint Association of serum albumin and atherosclerosis in chronic hemodialysis patients
    Srinivasan Beddhu
    National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
    Am J Kidney Dis 40:721-7. 2002
    ..Because cardiovascular disease is the leading cause of death and hypoalbuminemia predicts mortality, hypoalbuminemia may be associated with atherosclerosis...
  43. ncbi request reprint A crossover study of short daily haemodialysis
    Alexander S Goldfarb-Rumyantzev
    University of Utah School of Medicine, and Veterans Affairs Salt Lake City 84112, USA
    Nephrol Dial Transplant 21:166-75. 2006
    ..Most of these previous studies however have not been performed with rigorous controls...
  44. ncbi request reprint Dialyzer membranes as determinants of the adequacy of dialysis
    Madhukar Chelamcharla
    Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
    Semin Nephrol 25:81-9. 2005
    ..Novel designs of dialyzers include the optimization of fluid flow path geometry and increasing the membrane pore selectivity for solutes by using nanotechnology...
  45. ncbi request reprint Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation
    Sergey B Zhuplatov
    Veterans Affairs Salt Lake City Healthcare System, Departments of Medicine, Pharmacology and Toxicology, and Biochemistry, University of Utah, Salt Lake City, Utah, USA
    Basic Clin Pharmacol Toxicol 99:431-9. 2006
    ....
  46. ncbi request reprint Revisiting the hemodialysis dose
    John K Leypoldt
    Dialysis Program, University of Utah, Salt Lake City, Utah 84112 5350, USA
    Semin Dial 19:96-101. 2006
    ..solutes be dependent on gender? 4) Should the dialysis dose for middle molecules be used in clinical practice? 5) What should be the dialysis dose when using hemodialysis treatment strategies that are more frequent than thrice weekly?..
  47. ncbi request reprint Arterial and venous smooth-muscle cells differ in their responses to antiproliferative drugs
    Seung Jung Kim
    Divsion of Nephrology, Ewha Women s University, Salt Lake City, UT 84112, USA
    J Lab Clin Med 144:156-62. 2004
    ....
  48. ncbi request reprint Patient preferences for in-center intense hemodialysis
    Nirupama Ramkumar
    Division of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA
    Hemodial Int 9:281-95. 2005
    ..Disruption of personal time, however, is an important consideration. Success of DHD program would depend on arrangements for transportation to dialysis unit...
  49. ncbi request reprint Development of a sustained-release system for perivascular delivery of dipyridamole
    Weiwei Zhu
    Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, 84108, USA
    J Biomed Mater Res B Appl Biomater 77:135-43. 2006
    ..In vivo release of dipyridamole from microspheres/ReGel exhibited a comparable release pattern to that seen in vitro. This injectable platform is a promising technique for sustained perivascular delivery of antiproliferative drugs...
  50. ncbi request reprint Dialyzer performance in the HEMO Study: in vivo K0A and true blood flow determined from a model of cross-dialyzer urea extraction
    Thomas A Depner
    Hemodialysis HEMO Study Group, National Institutes of Health, Bethesda, MD, USA
    ASAIO J 50:85-93. 2004
    ....
  51. ncbi request reprint Different signaling responses to anti-proliferative agents in human aortic and venous smooth muscle cells
    Ray M Lee
    Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA
    J Cell Biochem 99:835-44. 2006
    ..In contrast, p38 MAPK is an important pro-survival regulator in VSMCs and p42/44 MAPK appears to play a minor role in responding to anti-proliferative drugs...
  52. ncbi request reprint Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells
    Li Li
    Department of Medicine, University of Utah, 85 North Medical Drive East, Salt Lake City, UT 84112, USA
    J Cell Biochem 99:1553-63. 2006
    ..These data highlight inherent pharmacodynamic differences between VSMC and ASMC in receptor and cell signaling functions and suggest that imatinib therapy may be useful for the prevention of venous stenosis in vascular grafts...
  53. ncbi request reprint Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa
    Usha R Thekkedath
    Research and Medical Service, George E Wahlen Department of Veterans Afairs Medical Center, and University of Utah School of Medicine Salt Lake City, UT 84148, USA
    Am J Hematol 81:915-26. 2006
    ..The decrease in plasma levels of FF > 100 kDa following HD suggests that adsorption to the dialysis membrane contributes to their removal...
  54. doi request reprint Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study
    Ron Wald
    Division of Nephrology and The Keenan Research Centre in the Li Ka Shing Knowledge Institute of St Michael s Hospital, Toronto, Ontario, Canada
    Am J Kidney Dis 52:531-40. 2008
    ..Although the values of these markers often evolve over time, no study has examined the accumulated effects of these abnormalities on important clinical end points...
  55. ncbi request reprint Effect of dialysis dose and membrane flux in maintenance hemodialysis
    Garabed Eknoyan
    Baylor College of Medicine, Houston, USA
    N Engl J Med 347:2010-9. 2002
    ..The effects of the dose of dialysis and the level of flux of the dialyzer membrane on mortality and morbidity among patients undergoing maintenance hemodialysis are uncertain...
  56. ncbi request reprint Hollow fiber shape alters solute clearances in high flux hemodialyzers
    John K Leypoldt
    Research Service, VA Salt Lake City Health Care System, UT, USA
    ASAIO J 49:81-7. 2003
    ..We conclude that the mass transfer characteristics of high flux dialyzers can be altered by the shape of the hollow fibers...
  57. ncbi request reprint Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint
    Prabir Roy-Chaudhury
    Division of Nephrology, MSB G 251, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267 0585
    J Am Soc Nephrol 17:1112-27. 2006
    ....
  58. ncbi request reprint Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?
    Bonnie C H Kwan
    Prince of Wales Hospital, Hong Kong
    Nat Clin Pract Nephrol 2:76-7. 2006
  59. ncbi request reprint Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction
    Michel Chonchol
    Division of Renal Diseases and Hypertension, University of Colorado Health Sciences Center, Denver, Colo 80262, USA
    Am J Nephrol 27:7-14. 2007
    ..It is, however, unclear if the risk and risk factors of SCD in these patients is modulated by the coexistence of mild chronic renal insufficiency...
  60. ncbi request reprint Lipoprotein metabolism and lipid management in chronic kidney disease
    Bonnie C H Kwan
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
    J Am Soc Nephrol 18:1246-61. 2007
  61. ncbi request reprint The HEMO Study: applicability and generalizability
    Michael V Rocco
    Wake Forest University School of Medicine, Department of Internal Medicine Nephrology, Medical Center Boulevard, Winston Salem, NC 27157 1053, USA
    Nephrol Dial Transplant 20:278-84. 2005
  62. ncbi request reprint Improving outcomes in CKD and ESRD patients: carrying the torch from training to practice
    Allen R Nissenson
    Department of Medicine, Division of Nephrology, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, USA
    Semin Dial 17:380-97. 2004
    ..If nephrologists are to take their appropriate place as leaders of the care delivery team, nephrology fellowships must be restructured with appropriate emphasis placed on the comprehensive care of ESRD and CKD patients...
  63. ncbi request reprint Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study
    James A Delmez
    Washington University, St Louis, MO, USA
    Am J Kidney Dis 47:131-8. 2006
    ....
  64. ncbi request reprint Different responses by cultured aortic and venous smooth muscle cells to gamma radiation
    Seung Jung Kim
    Division of Nephrology, Ewha Women s University, Seoul, Korea
    Kidney Int 68:371-7. 2005
    ..External radiation of the graft is a potential strategy to prevent stenosis; however, the relative responsiveness of arterial and venous SMCs to radiation is unknown...
  65. ncbi request reprint The career of Lee W. Henderson
    Jonas Bergstrom
    Karolinska Institute, Huddinge, Sweden
    J Am Soc Nephrol 13:S1-2. 2002

Research Grants9

  1. PREVENTION OF HEMODIALYSIS VASCULAR ACCESS STENOSIS
    Alfred Cheung; Fiscal Year: 2004
    ..Furthermore, the results will provide the basis for local delivery of drugs and proteins of interest to a variety of tissues. ..
  2. PREVENTION OF HEMODIALYSIS VASCULAR ACCESS STENOSIS
    Alfred Cheung; Fiscal Year: 2007
    ..It is highly likely that, within this 5-year proposal, the results of this project can be applied to pilot clinical studies. ..
  3. PREVENTION OF HEMODIALYSIS VASCULAR ACCESS STENOSIS
    Alfred Cheung; Fiscal Year: 2009
    ..It is highly likely that, within this 5-year proposal, the results of this project can be applied to pilot clinical studies. ..
  4. PREVENTION OF HEMODIALYSIS VASCULAR ACCESS STENOSIS
    Alfred K Cheung; Fiscal Year: 2010
    ..It is highly likely that, within this 5-year proposal, the results of this project can be applied to pilot clinical studies. ..